Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression changes by Glyceollin I treatment of breast cancer cells

ABSTRACT: Gene expression changes by Glyceollin I treatment of breast cancer cells

PROVIDER: PRJNA902037 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR22306600_1.fastq.gz	Fastqsanger.gz
	SRR22306600_2.fastq.gz	Fastqsanger.gz
	SRR22306601_1.fastq.gz	Fastqsanger.gz
	SRR22306601_2.fastq.gz	Fastqsanger.gz
	SRR22306602_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 48

Similar Datasets

Gene expression changes in mouse breast cancer cells (EMT6) after anti-PD-L1 treatment

Project description:Gene expression changes in mouse breast cancer cells (EMT6) after anti-PD-L1 treatment

| PRJNA772174 | ENA

Gene expression changes in triple-negative breast cancer by glucose restriction and cariporide treatment

Project description:Gene expression changes in triple-negative breast cancer by glucose restriction and cariporide treatment

| PRJNA1145351 | ENA

Transcriptome changes after curcumin analog treatment in HER2+ breast cancer cells

Project description:Transcriptome changes after curcumin analog treatment in HER2+ breast cancer cells

| PRJNA901937 | ENA

Multi-treatment models for breast cancer

Project description:Multi-treatment models for breast cancer

| PRJNA563821 | ENA

Gene expression change after JQ1 treatment in breast cancer cell

Project description:Gene expression change after JQ1 treatment in breast cancer cell

| PRJNA587994 | ENA

A pooled treatment-curated breast cancer gene-expression dataset

Project description:Pre-clinical studies reported the immunogenic or immunomodulatory effects of traditional cancer therapies. However, the publicly available well-curated and harmonized breast cancer datasets, such as TCGA, METABRIC, and MetaGxBreast, lack careful curation of treatment regimens. Hence, limited exploration of the impact of therapies on the prognostic/predictive value of breast cancer biomarkers. Herein, we describe a pooled and treatment-curated gene-expression dataset to investigate the impact of treatments on the prognostic/predictive value of biomarkers. We searched the gene expression omnibus database to identify potential human breast cancer gene-expression datasets with anthracycline/taxane treatment. Published datasets with the detailed treatment regimen, clinical endpoint, clinical-pathological, and gene-expression data were extracted and harmonized. The dataset described herein would help researchers explore the interaction between gene-expression biomarkers and immunogenic/immunomodulatory treatments in breast cancer.

2024-03-09 | GSE205568 | GEO

Gene expression changes in mouse breast cancer cells (EMT6) after anti-PD-L1 treatment

Project description:RNA sequencing analysis was used to identify changes in mouse breast cancer (EMT6) following prolonged anti-PD-L1 in vitro (PDRvitro).

2024-10-14 | GSE186034 | GEO

Statin-induced transcriptional changes in breast cancer

Project description:Global gene expression profiling was performed on [1] paired tumor biopsies collected before and after 2 weeks of statin treatment [2] a collection of breast cancer cells lines following 48hrs of atorvastatin treatment with the aim of detecting statin induced transcriptional changes in breast cancer cells in-vitro.

2015-06-23 | GSE63427 | GEO

Gene expression changes after epinephrine treated in breast cancer tumor cell

Project description:Gene expression changes after epinephrine treated in breast cancer tumor cell

| PRJNA480241 | ENA

MSC-induced lncRNA expression changes in breast cancer cells

Project description:MSC-induced lncRNA expression changes in breast cancer cells

| PRJNA718527 | ENA